165 related articles for article (PubMed ID: 28898910)
1. Balanced Coagonist of GLP-1 and Glucagon Receptors Corrects Dyslipidemia by Improving FGF21 Sensitivity in Hamster Model.
Patel V; Joharapurkar A; Kshirsagar S; Patel HM; Pandey D; Patel D; Sutariya B; Patel M; Bahekar R; Jain MR
Drug Res (Stuttg); 2017 Dec; 67(12):730-736. PubMed ID: 28898910
[TBL] [Abstract][Full Text] [Related]
2. Activation of GLP-1 and Glucagon Receptors Regulates Bile Homeostasis Independent of Thyroid Hormone.
Patel VJ; Joharapurkar AA; Kshirsagar SG; Sutariya BK; Patel MS; Bahekar RH; Jain MR
Curr Mol Pharmacol; 2019; 12(2):139-146. PubMed ID: 30747091
[TBL] [Abstract][Full Text] [Related]
3. Central administration of coagonist of GLP-1 and glucagon receptors improves dyslipidemia.
Patel V; Joharapurkar A; Kshirsagar S; Sutariya B; Patel M; Patel H; Pandey D; Patel D; Bahekar R; Jain M
Biomed Pharmacother; 2018 Feb; 98():364-371. PubMed ID: 29275178
[TBL] [Abstract][Full Text] [Related]
4. Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition.
Patel V; Joharapurkar A; Kshirsagar S; Sutariya B; Patel M; Pandey D; Patel H; Ranvir R; Kadam S; Patel D; Bahekar R; Jain M
Chem Biol Interact; 2018 Feb; 282():13-21. PubMed ID: 29325849
[TBL] [Abstract][Full Text] [Related]
5. Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease.
Patel V; Joharapurkar A; Kshirsagar S; Patel M; Sutariya B; Patel H; Pandey D; Patel D; Ranvir R; Kadam S; Bahekar R; Jain M
Can J Physiol Pharmacol; 2018 Jun; 96(6):587-596. PubMed ID: 29406832
[TBL] [Abstract][Full Text] [Related]
6. Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease.
Patel V; Joharapurkar A; Kshirsagar S; Sutariya B; Patel M; Patel H; Pandey D; Patel D; Ranvir R; Kadam S; Bahekar R; Jain M
Cardiovasc Hematol Agents Med Chem; 2018; 16(1):35-43. PubMed ID: 29357809
[TBL] [Abstract][Full Text] [Related]
7. Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice.
Patel V; Joharapurkar A; Dhanesha N; Kshirsagar S; Patel K; Bahekar R; Shah G; Jain M
Can J Physiol Pharmacol; 2013 Dec; 91(12):1009-15. PubMed ID: 24289070
[TBL] [Abstract][Full Text] [Related]
8. Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus.
Patel VJ; Joharapurkar AA; Kshirsagar SG; Sutariya BK; Patel MS; Patel HM; Pandey DK; Bahekar RH; Jain MR
World J Diabetes; 2018 Jun; 9(6):80-91. PubMed ID: 29988851
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
[TBL] [Abstract][Full Text] [Related]
10. Central and Peripheral Glucagon Reduces Hyperlipidemia in Rats and Hamsters.
Patel V; Joharapurkar A; Kshirsagar S; Patel HM; Pandey D; Patel D; Shah K; Bahekar R; Shah GB; Jain MR
Drug Res (Stuttg); 2017 Jun; 67(6):318-326. PubMed ID: 28445900
[TBL] [Abstract][Full Text] [Related]
11. Combination of Lorcaserin and GLP-1/glucagon Coagonist Improves Metabolic Dysfunction in Diet Induced-obese Mice.
Patel V; Joharapurkar A; Kshirsagar S; Patel M; Savsani H; Bahekar R; Jain M
Drug Res (Stuttg); 2020 Aug; 70(8):376-384. PubMed ID: 32645724
[TBL] [Abstract][Full Text] [Related]
12. GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet.
Clemmensen C; Chabenne J; Finan B; Sullivan L; Fischer K; Küchler D; Sehrer L; Ograjsek T; Hofmann SM; Schriever SC; Pfluger PT; Pinkstaff J; Tschöp MH; Dimarchi R; Müller TD
Diabetes; 2014 Apr; 63(4):1422-7. PubMed ID: 24379349
[TBL] [Abstract][Full Text] [Related]
13. A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis.
Pan Q; Lin S; Li Y; Liu L; Li X; Gao X; Yan J; Gu B; Chen X; Li W; Tang X; Chen C; Guo L
EBioMedicine; 2021 Jan; 63():103202. PubMed ID: 33421947
[TBL] [Abstract][Full Text] [Related]
14. Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output.
Liu J; Yang K; Yang J; Xiao W; Le Y; Yu F; Gu L; Lang S; Tian Q; Jin T; Wei R; Hong T
EBioMedicine; 2019 Mar; 41():73-84. PubMed ID: 30827929
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge.
Liu D; Pang J; Shao W; Gu J; Zeng Y; He HH; Ling W; Qian X; Jin T
Hepatology; 2021 Oct; 74(4):2154-2169. PubMed ID: 33851458
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
[TBL] [Abstract][Full Text] [Related]
17. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice.
Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H
J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets.
Le TDV; Fathi P; Watters AB; Ellis BJ; Besing GK; Bozadjieva-Kramer N; Perez MB; Sullivan AI; Rose JP; Baggio LL; Koehler J; Brown JL; Bales MB; Nwaba KG; Campbell JE; Drucker DJ; Potthoff MJ; Seeley RJ; Ayala JE
Mol Metab; 2023 Jun; 72():101718. PubMed ID: 37030441
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptor negatively regulates fibroblast growth factor 21 in the fatty liver induced by cholesterol-enriched diet.
Uebanso T; Taketani Y; Yamamoto H; Amo K; Tanaka S; Arai H; Takei Y; Masuda M; Yamanaka-Okumura H; Takeda E
J Nutr Biochem; 2012 Jul; 23(7):785-90. PubMed ID: 21889884
[TBL] [Abstract][Full Text] [Related]
20. The modulating effect of Persea americana fruit extract on the level of expression of fatty acid synthase complex, lipoprotein lipase, fibroblast growth factor-21 and leptin--A biochemical study in rats subjected to experimental hyperlipidemia and obesity.
Monika P; Geetha A
Phytomedicine; 2015 Sep; 22(10):939-45. PubMed ID: 26321743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
